Free Trial
→ Elon Musk is all in on these robots … (From Weiss Ratings) (Ad)
NASDAQ:GCTK

GlucoTrack 8/14/2023 Earnings Report

GlucoTrack logo
$0.18 +0.02 (+9.31%)
Closing price 05/5/2025 04:00 PM Eastern
Extended Trading
$0.17 -0.02 (-9.98%)
As of 04:42 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Earnings History

GlucoTrack EPS Results

Actual EPS
-$9.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GlucoTrack Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GlucoTrack Announcement Details

Quarter
Date
8/14/2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

GlucoTrack's Q1 2025 earnings is scheduled for Wednesday, May 21, 2025

Conference Call Resources

GlucoTrack Earnings Headlines

GlucoTrack to participate in FORGETDIABETES initiative
April 17, 2025 | markets.businessinsider.com
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas
April 16, 2025 | globenewswire.com
Elon Musk is all in on these robots …
Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang said, "The ChatGPT moment for robotics is right around the corner." In fact, I believe these robots could impact 65 million Americans lives — this year. And one stock — currently priced around $7 — could be the biggest winner.
May 6, 2025 | Weiss Ratings (Ad)
GlucoTrack, OneTwo Analytics collaborate to study analysis on CBG Monitor
April 5, 2025 | markets.businessinsider.com
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor
April 3, 2025 | globenewswire.com
Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights
March 31, 2025 | globenewswire.com
See More GlucoTrack Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GlucoTrack? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GlucoTrack and other key companies, straight to your email.

About GlucoTrack

GlucoTrack (NASDAQ:GCTK), a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

View GlucoTrack Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles